Is this you? Create Your Porfile
Avatar

Helen L. Twigger

University of Nottingham

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Helen L. Twigger is active.

Explore More

Publication

Featured researches published by Helen L. Twigger.

Tetrahedron Letters | 1997

ORGANOCERIUM REACTIONS OF BENZAMIDES AND THIOBENZAMIDES : A DIRECT SYNTHESIS OF TERTIARY CARBINAMINES

David J. Calderwood; Roy V. Davies; Paul Rafferty; Helen L. Twigger; Helen M. Whelan

Abstract A simple and efficient process has been developed for the direct conversion of benzamides and thiobenzamides into tertiary carbinamines. A synthesis of benzonitriles from simple benzamides and a thiobenzamide is also described.

Archive | 1999

4-aminopyrrolopyrimidines as kinase inhibitors

David J. Calderwood; Lee D. Arnold; Hormoz Mazdiyasni; Gavin C. Hirst; Bojuan B. Deng; David N. Johnston; Paul Rafferty; Gerald Bernard Tometzki; Helen L. Twigger; Rainer Munschauer

Archive | 1998

Pyrrolo 2,3d]pyrimidines and their use as tyrosine kinase inhibitors

David J. Calderwood; David N. Johnston; Paul Rafferty; Helen L. Twigger; Rainer Munschauer; Lee D. Arnold

Archive | 1998

Substituted 4-amino-7H-pyrrolo [2,3,-d]-pyrimidines as PTK inhibitors

David J. Calderwood; David N. Johnston; Paul Rafferty; Helen L. Twigger; Rainer Munschauer; Lee D. Arnold

Archive | 2000

Inhibidores de kinasa utilizados como agentes terapeuticos.

David J. Calderwood; Gavin C. Hirst; Paul Rafferty; Kurt Ritter; Stephen Loughborough St.Gallay; Helen L. Twigger

Archive | 2000

Kinaseinhibitoren als arzneimittel Kinase inhibitors as drug

David Framingham Calderwood; Gavin C. Hirst; Paul Westborough Rafferty; Kurt Ritter; Stephen Loughborough St.Gallay; Helen L. Twigger

Archive | 2000

Kinase inhibitors as drug

David Framingham Calderwood; Gavin C. Hirst; Paul Westborough Rafferty; Kurt Ritter; Stephen Loughborough St.Gallay; Helen L. Twigger

Archive | 2000

Inaseinkibitorer as therapeutic agents

Kurt Ritter; Gallay Stephen St; Gavin C. Hirst; Paul Rafferty; David J. Calderwood; Helen L. Twigger

Archive | 2000

Inaseinkibitorer som terapeutiske midler

Kurt Ritter; Gallay Stephen St; Gavin C. Hirst; Paul Rafferty; David J. Calderwood; Helen L. Twigger

Archive | 2000

Inhibiteurs de kinase utilises comme agents therapeutiques

David J. Calderwood; Gavin C. Hirst; Paul Rafferty; Kurt Ritter; Gallay Stephen St; Helen L. Twigger

Explore More

Collaboration

Dive into the Helen L. Twigger's collaboration.

Top Co-Authors
Avatar

David J. Calderwood

University of Nottingham

View shared research outputs
Top Co-Authors
Avatar

Paul Rafferty

University of Nottingham

View shared research outputs
Top Co-Authors
Avatar

Gavin C. Hirst

Research Triangle Park

View shared research outputs
Top Co-Authors
Avatar

David N. Johnston

University of Nottingham

View shared research outputs
Top Co-Authors
Avatar

Lee D. Arnold

OSI Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Kurt Ritter

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Rainer Munschauer

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

David Framingham Calderwood

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Paul Westborough Rafferty

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Helen M. Whelan

University of Nottingham

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge